Status:
COMPLETED
Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The new coronavirus known as SARS-Cov-2 (severe acute respiratory syndrome -coronavirus 2) was first reported in December 2019 and rapidly became a public health emergency. The COVID-19 pandemic is no...
Eligibility Criteria
Inclusion
- Free and informed consent accepted in writing
- Patient: patient hospitalized in one of the four hospitals of Bamako, with clinical signs of infection of the upper or lower respiratory tracts (sore throat, cough/sputum, nasal congestion and rhinorrhea, odynophagia, thoracic oppression, dyspnea, desaturation) with fever or feeling of fever or any other signs of SARS-Cov-2 infection (that is to say the following clinical manifestations, of sudden onset: unexplained asthenia, unexplained myalgia, headache without a known migraine disease, anosmia or hyposmia without associated rhinitis, dysgueusia, diarrhea, heart rhythm disorders, acute myocardial injury, severe thromboembolic event) or who have been in close contact with a SARS-CoV-2 infected person without effective protective measures (FFP2/surgical masks or physical separation) and defined as follows: having shared the same place of life as the confirmed case, for example: family, same room or having a direct contact in face to face with less than 1 meter from the confirmed case during a talk; intimate friends; class or office neighbours; adjacent to the index case in a plane or a train; or having provided or received hygiene or care acts from a confirmed case.
- Caregivers: caregivers of one of the four hospitals of Bamako
Exclusion
- Persons subject to legal protection or not able to give a free and informed consent.
- Caregivers: caregivers not able to follow the project schedule
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04710316
Start Date
February 15 2021
End Date
September 30 2022
Last Update
December 12 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital du Point-G
Bamako, Mali
2
Hopital Gabriel Toure
Bamako, Mali
3
Hôpital dermatologique de Bamako
Bamako, Mali
4
Hôpital du Mali
Bamako, Mali